Recent clinical research demonstrates that atorvastatin 40mg daily significantly reduces cardiovascular risks in older British adults. A comprehensive trial involving nearly 10,000 participants aged 70 and above, without existing heart disease, diabetes, or dementia, revealed a 30% decrease in major cardiovascular events. This breakthrough findings address previous safety concerns and provide evidence-based guidance for elderly patients considering statin therapy as a preventive health measure.

Summary auto-generated by AI from the original publisher's content. Editorial standards.